Epigenetic instability and chromosomal instability in hepatocellular carcinoma

被引:48
作者
Katoh, H
Shilbata, T
Kokubu, A
Ojima, H
Fukayama, M
Kanai, Y
Hirohashi, S
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Canc Genom Project, Tokyo 1040045, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan
关键词
D O I
10.2353/ajpath.2006.050989
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of this study was to clarify the association between the epigenetic instability phenotype and the chromosomal instability phenotype in primary hepatocellular carcinoma (HCC). Sixty primary HCC tumors were examined. Methylation status for nine CpG islands (the p16, COX2, GSTP1, RASSF1A, E-cadherin, and APC gene promoters, and the MINT 1, 25, and 31 clones) was evaluated by methylation-specific polymerase chain reaction. Chromosomal structural alterations of these 60 HCC tumors were characterized in our previous study by using whole genomic array-based comparative genomic hybridization. We found that the epigenetic instability phenotype and the chromosomal instability phenotype are not mutually exclusive in hepatocarcinogenesis and that they do not show a simple cause-and-effect relationship. Hepatitis virus infection in the background liver was significantly associated with these instability phenotypes. Furthermore, we identified an epigenetic instability-dependent HCC that shows frequent epigenetic aberrations without chromosomal instability. it was noteworthy that epigenetic instability-positive and -negative HCCs displayed distinctive combinations of chromosomal structural alterations. In summary, by combined analyses of genetic and epigenetic aberration profiles in HCC, we obtained a comprehensive view of genomic alterations in hepatocarcinogenesis. Our results have clinical relevance because epigenetic instability-dependent HCCs may respond well to methylation inhibitory therapies.
引用
收藏
页码:1375 / 1384
页数:10
相关论文
共 38 条
  • [1] Mechanisms of human hepatocarcinogenesis
    Coleman, WB
    [J]. CURRENT MOLECULAR MEDICINE, 2003, 3 (06) : 573 - 588
  • [2] Eads CA, 2000, CANCER RES, V60, P5021
  • [3] Chromosomal instability and tumors promoted by DNA hypomethylation
    Eden, A
    Gaudet, F
    Waghmare, A
    Jaenisch, R
    [J]. SCIENCE, 2003, 300 (5618) : 455 - 455
  • [4] Rising incidence of hepatocellular carcinoma in the United States
    El-Serag, HB
    Mason, AC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) : 745 - 750
  • [5] Induction of tumors in mice by genomic hypomethylation
    Gaudet, F
    Hodgson, JG
    Eden, A
    Jackson-Grusby, L
    Dausman, J
    Gray, JW
    Leonhardt, H
    Jaenisch, R
    [J]. SCIENCE, 2003, 300 (5618) : 489 - 492
  • [6] DNA methyltransferase inhibitors - state of the art
    Goffin, J
    Eisenhauer, E
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (11) : 1699 - 1716
  • [7] CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome
    Heisler, LE
    Torti, D
    Boutros, PC
    Watson, J
    Chan, C
    Winegarden, N
    Takahashi, M
    Yau, P
    Huang, THM
    Farnham, PJ
    Jurisica, I
    Woodgett, JR
    Bremner, R
    Penn, LZ
    Der, SD
    [J]. NUCLEIC ACIDS RESEARCH, 2005, 33 (09) : 2952 - 2961
  • [8] Distinct epigenetic changes in the stromal cells of breast cancers
    Hu, M
    Yao, J
    Cai, L
    Bachman, KE
    van den Brûle, F
    Velculescu, V
    Polyak, K
    [J]. NATURE GENETICS, 2005, 37 (08) : 899 - 905
  • [9] Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes
    Inazawa, J
    Inoue, J
    Imoto, I
    [J]. CANCER SCIENCE, 2004, 95 (07) : 559 - 563
  • [10] Opinion - CpG island methylator phenotype in cancer
    Issa, JP
    [J]. NATURE REVIEWS CANCER, 2004, 4 (12) : 988 - 993